What was the overall market valuation of the equine healthcare market in 2024?

The overall market valuation was $77.81 Million in 2024. Read More

What is the projected market valuation for the equine healthcare market by 2035?

The projected valuation for 2035 is $96.7 Million. Read More

What is the expected CAGR for the equine healthcare market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 2.0%. Read More

Which segment had the highest valuation in 2024 within the equine healthcare market?

The Pharmaceuticals segment had the highest valuation at $25.0 Million in 2024. Read More

What are the projected values for the Diagnostics segment by 2035?

The projected value for the Diagnostics segment is $18.0 Million by 2035. Read More

Which key player is associated with the equine healthcare market?

Key players include Merck Animal Health, Zoetis, and Boehringer Ingelheim. Read More

What was the valuation of the Musculoskeletal Disorders segment in 2024?

The Musculoskeletal Disorders segment was valued at $15.0 Million in 2024. Read More

How much is the E-commerce distribution channel expected to generate by 2035?

The E-commerce distribution channel is expected to generate $30.0 Million by 2035. Read More

What is the projected value for the Sports/Racing activity segment by 2035?

The projected value for the Sports/Racing activity segment is $38.0 Million by 2035. Read More

What was the valuation of the Others segment in the Pharmaceuticals category in 2024?

The Others segment in the Pharmaceuticals category was valued at $9.81 Million in 2024. Read More

Italy Equine Healthcare Market

ID: MRFR/HC/50664-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

Italy Equine Healthcare Market Research Report: Size, Share, Trend Analysis By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others), By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others), By Activity (Sports/Racing, Recreation, Others) and By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Italy Equine Healthcare Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)2.0%

2024 Market Size$ 77.81 Million

2025 Market Size$ 79.37 Million

2035 Market Size$ 96.7 Million

Key Players

Merck Animal Health

Zoetis

Boehringer Ingelheim

Elanco Animal Health

Vetoquinol

Dechra Pharmaceuticals

Trends

Rising Demand for Preventive Care
Technological Advancements in Veterinary Services
Increased Awareness of Animal Welfare

Opportunities

Advancements in Equine Nutrition
Growing Investment in Equine Health
Rising Popularity of Equestrian Sports

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Product (USD Million)
  1. 4.1.1 Vaccines
  2. 4.1.2 Pharmaceuticals
  3. 4.1.3 Medicinal Feed Additives
  4. 4.1.4 Diagnostics
  5. 4.1.5 Software & Services
  6. 4.1.6 Others
2. 4.2 Security, Access Control and Robotics, BY Indication (USD Million)
  1. 4.2.1 Musculoskeletal Disorders
  2. 4.2.2 Parasite Control
  3. 4.2.3 Internal Medicine
  4. 4.2.4 Equine Herpes Virus
  5. 4.2.5 Equine Encephalomyelitis
  6. 4.2.6 Equine Influenza
  7. 4.2.7 West Nile Virus
  8. 4.2.8 Tetanus
  9. 4.2.9 Others
3. 4.3 Security, Access Control and Robotics, BY Activity (USD Million)
  1. 4.3.1 Sports/Racing
  2. 4.3.2 Recreation
  3. 4.3.3 Others
4. 4.4 Security, Access Control and Robotics, BY Distribution Channel (USD Million)
  1. 4.4.1 Veterinary Hospitals & Clinics
  2. 4.4.2 E-commerce
  3. 4.4.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Merck Animal Health (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Zoetis (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boehringer Ingelheim (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Elanco Animal Health (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Vetoquinol (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Dechra Pharmaceuticals (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cegelec (FR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Heska Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Vetmedin (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 ITALY MARKET ANALYSIS BY PRODUCT
3. 6.3 ITALY MARKET ANALYSIS BY INDICATION
4. 6.4 ITALY MARKET ANALYSIS BY ACTIVITY
5. 6.5 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
9. 6.9 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
12. 6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT, 2024 (% SHARE)
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY PRODUCT, 2024 TO 2035 (USD Million)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY INDICATION, 2024 (% SHARE)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY INDICATION, 2024 TO 2035 (USD Million)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY ACTIVITY, 2024 (% SHARE)
17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY ACTIVITY, 2024 TO 2035 (USD Million)
18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  2. 7.2.2 BY INDICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY ACTIVITY, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Italy Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Product (USD Million, 2025-2035)

Vaccines
Pharmaceuticals
Medicinal Feed Additives
Diagnostics
Software & Services
Others

Security, Access Control and Robotics By Indication (USD Million, 2025-2035)

Musculoskeletal Disorders
Parasite Control
Internal Medicine
Equine Herpes Virus
Equine Encephalomyelitis
Equine Influenza
West Nile Virus
Tetanus
Others

Security, Access Control and Robotics By Activity (USD Million, 2025-2035)

Sports/Racing
Recreation
Others

Security, Access Control and Robotics By Distribution Channel (USD Million, 2025-2035)

Veterinary Hospitals & Clinics
E-commerce
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”